3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma
3
Triple Negative Breast Neoplasms
2
Glioblastoma
2
Squamous Cell Carcinoma of Head and Neck
1
Smoldering Multiple Myeloma
1
Pancreatic Neoplasms
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Liver Neoplasms
1
Glioma
1
Fibrolamellar hepatocellular carcinoma
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Breast Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
Cyclophosphamide
26
fludarabine
18
Dexamethasone
17
pembrolizumab
12
Rituximab
11
Etoposide
10
venetoclax
9
pomalidomide
9
Gemcitabine
9
fludarabine phosphate
7
daratumumab
7
Lenalidomide
7
Bortezomib
7
carfilzomib
6
obinutuzumab
5
glofitamab
5
Vincristine
5
Temozolomide
5
Prednisone
5
Nivolumab
5
Immunotherapy, Adoptive
5
Cisplatin
5
Calcium Dobesilate
5
selinexor
4
cemiplimab
4
Doxorubicin
4
Cytarabine
4
Carboplatin
4
zanubrutinib
3
ruxolitinib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Recurrence
×
poly ICLC
×
90 days
×
Clear all
No trials found.